Cell Signaling & Oncology

Axon Ligands™ for Cell Signaling & Oncology Research

The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer. During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. These interconnected pathways are being deciphered, but understanding the alterations that lead to cancer and correcting them is a substantial challenge. Among the key pathways are those controlling cell proliferation, which coordinate a response to the cellular environment, with the mTOR kinase as a critical node. Tumour development is influenced by infections and inflammation, and the complex role of the nuclear factor-B transcription factors is being unravelled. Expansion of tumour cells depends on nutrient supply and vascularization, which is orchestrated by the transcription factor known as HIF. And the metastatic spread of primary tumours to other organs is facilitated by many signaling pathways[1],[2].

Cell Signaling and Oncology products Library

For your convenience, you can order a library of all of our Cell Signaling and Oncology research related products. Make your personal library by cherry picking products of your interest from our comprehensive list (>800 products), or order all together not to miss any. The libraries will be shipped as 10 mM solutions (in DMSO, 250 µL of each selected Axon Ligand™) on a 96-well microtiter plate with a clear map of its contents.

Simply download our comprehensive list of epigenetics products below (Microsoft Excel (.xls)), check the products to be included, and return your list to order the library of your preference.

Axon Ligands™ for Epigenetic research   Axon 5051 - Cell signaling and Oncology Library.xls                   

 

[1] A. Eccleston, R. Dhand. Signalling in cancer. Nature 441, 423, editorial note
[2] G.S. Martin. Cell signaling and cancer. Cancer Cell. 2003 Sep;4(3):167-74.

10 Item(s)

per page
Axon ID Name Description From price
2930 Alofanib Allosteric inhibitor of FGFR2 €90.00
1917 AZD4547 Potent and selective FGFR inhibitor €85.00
4067 Formononetin Potent FGFR2 inhibitor €120.00
1981 LY 2874455 Potent and selective FGFR inhibitor €110.00
1775 NVP-BGJ398 Inhibitor of FGFR tyrosine kinases 1, 2 ,3 and 4 €80.00
1944 NVP-BGJ398 phosphate Inhibitor of FGFR tyrosine kinases 1, 2 ,3 and 4 €90.00
2098 PD161570 Selective FGFR1 inhibitor €75.00
1673 PD173074 FGFR1 and FGFR3 inhibitor €75.00
2953 Roblitinib First-in-class, highly selective and potent FGFR4 inhibitor €125.00
2234 SSR 128129E Allosteric inhibitor of FGF receptor signaling €110.00

10 Item(s)

per page
Please wait...